Praxis Precision Medicines (NASDAQ: PRAX) director files Form 3 reporting no owned shares
Rhea-AI Filing Summary
Praxis Precision Medicines director reports no share ownership
Praxis Precision Medicines, Inc. director Arbuckle Stuart A filed an initial insider ownership report. The filing states that no securities of Praxis Precision Medicines are beneficially owned by the reporting person as of the event date of January 8, 2026. The form is filed by a single reporting person and is signed by an attorney-in-fact, supported by a power of attorney.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Praxis Precision Medicines (PRAX) Form 3 filing show?
The Form 3 shows that director Arbuckle Stuart A reported no beneficial ownership of Praxis Precision Medicines, Inc. securities as of the stated event date.
Who is the reporting person in the PRAX Form 3?
The reporting person is Arbuckle Stuart A, who is identified in the filing as a director of Praxis Precision Medicines, Inc.
Is this PRAX Form 3 filed by one or multiple reporting persons?
The filing is marked as Form filed by One Reporting Person, meaning only Arbuckle Stuart A is covered by this report.
Who signed the Praxis Precision Medicines (PRAX) Form 3?
The Form 3 is signed /s/ Alex Nemiroff, as Attorney-in-Fact, referencing an Exhibit 24 - Power of Attorney authorizing the signature.